BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33609852)

  • 1. Management of subcutaneous infiltration of rocuronium: A case report.
    Timmermann TN; Mongan PD; Hoefnagel AL; Braunecker S
    J Clin Anesth; 2021 Aug; 71():110203. PubMed ID: 33609852
    [No Abstract]   [Full Text] [Related]  

  • 2. Does the pretreatment of magnesium sulphate affect the sugammadex reversal time for rocuronium-induced neuromuscular blockade? A meta-analysis.
    Miao M; Zhang J
    J Clin Anesth; 2020 Mar; 60():78-79. PubMed ID: 31476625
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High need for sugammadex for rocuronium reversal with acute renal failure and normal need in the same patient with no renal impairment.
    Valente A
    J Clin Anesth; 2020 Dec; 67():109981. PubMed ID: 32682252
    [No Abstract]   [Full Text] [Related]  

  • 5. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.
    de Boer HD; van Egmond J; Driessen JJ; Booij LH
    Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No effect of intraoperative rocuronium doses on 30-day postoperative complications after sugammadex reversal in patients undergoing gastrointestinal surgery.
    Onoe K; Ogata H; Ishimoto D; Kaneko T; Ueki R; Kariya N; Tatara T; Hirose M
    J Clin Anesth; 2020 May; 61():109662. PubMed ID: 31759814
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sugammadex, a novel drug for neuromuscular blockade reversal].
    Fernández Meré LA; Alvarez-Blanco M
    Rev Esp Anestesiol Reanim; 2010 Feb; 57(2):95-102. PubMed ID: 20337001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report.
    Kawano T; Tamura T; Hamaguchi M; Yatabe T; Yamashita K; Yokoyama M
    J Clin Anesth; 2012 Feb; 24(1):62-4. PubMed ID: 22154092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extremely prolonged neuromuscular block after a single dose of rocuronium].
    Menouni O; Brillouet-Banchereau AC; Galan G; Lélias A; Sautereau A; Gadrey S
    Ann Fr Anesth Reanim; 2011 Nov; 30(11):841-3. PubMed ID: 21983058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected Accidental Infiltration of Rocuronium During General Anesthesia Induction: A Case Report.
    Sakurai Y; Shibuya M; Okiji R; Hase Y; Hojo T; Kimura Y; Fujisawa T
    Anesth Prog; 2023 Sep; 70(3):116-119. PubMed ID: 37850674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sugammadex: the last shot for anaphylactic shock due to rocuronium?].
    Abad Gurumeta A; Gutiérrez García R
    Rev Esp Anestesiol Reanim; 2012 Apr; 59(4):177-9. PubMed ID: 22575774
    [No Abstract]   [Full Text] [Related]  

  • 13. Sugammadex in the management of rocuronium-induced anaphylaxis.
    McDonnell NJ; Pavy TJ; Green LK; Platt PR
    Br J Anaesth; 2011 Feb; 106(2):199-201. PubMed ID: 21149287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rocuronium-induced anaphylaxis not improved by low dose sugammadex: a case report.
    Hakozaki T; Murakawa M
    Anaesth Intensive Care; 2016 Jul; 44(4):522. PubMed ID: 27456189
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
    Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
    Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significantly prolonged neuromuscular blockade after a single dose of rocuronium: The importance of monitoring.
    Soares M; Esteves S
    Eur J Anaesthesiol; 2016 Sep; 33(9):693-4. PubMed ID: 27136491
    [No Abstract]   [Full Text] [Related]  

  • 17. Is sugammadex superior to neostigmine in reversing rocuronium-induced neuromuscular blockade?
    Bartlett E; Urman RD; Urits I; Kaye AD; Viswanath O
    J Clin Anesth; 2022 Aug; 79():110288. PubMed ID: 33875335
    [No Abstract]   [Full Text] [Related]  

  • 18. Extremely prolonged neuromuscular blockade after rocuronium: a case report.
    Morales Martín AC; Vaquero Roncero LM; Muriel Villoria C
    Acta Anaesthesiol Scand; 2009 Aug; 53(7):957-9. PubMed ID: 19397500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
    Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
    Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.
    Weekes G; Hayes N; Bowen M
    Int J Obstet Anesth; 2010 Jul; 19(3):333-6. PubMed ID: 20627694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.